Coronavirus disease 2019 in pregnancy was associated with maternal morbidity and preterm birth.


Journal

American journal of obstetrics and gynecology
ISSN: 1097-6868
Titre abrégé: Am J Obstet Gynecol
Pays: United States
ID NLM: 0370476

Informations de publication

Date de publication:
12 2020
Historique:
received: 07 05 2020
revised: 04 06 2020
accepted: 10 06 2020
pubmed: 20 6 2020
medline: 15 12 2020
entrez: 20 6 2020
Statut: ppublish

Résumé

Despite the mainly reassuring outcomes for pregnant women with coronavirus disease 2019 reported by previous case series with small sample sizes, some recent reports of severe maternal morbidity requiring intubation and of maternal deaths show the need for additional data about the impact of coronavirus disease 2019 on pregnancy outcomes. This study aimed to report the maternal characteristics and clinical outcomes of pregnant women with coronavirus disease 2019. This retrospective, single-center study includes all consecutive pregnant women with confirmed (laboratory-confirmed) or suspected (according to the Chinese management guideline [version 7.0]) coronavirus disease 2019, regardless of gestational age at diagnosis, admitted to the Strasbourg University Hospital (France) from March 1, 2020, to April 3, 2020. Maternal characteristics, laboratory and imaging findings, and maternal and neonatal outcomes were extracted from medical records. The study includes 54 pregnant women with confirmed (n=38) and suspected (n=16) coronavirus disease 2019. Of these, 32 had an ongoing pregnancy, 1 had a miscarriage, and 21 had live births: 12 vaginal and 9 cesarean deliveries. Among the women who gave birth, preterm deliveries were medically indicated for their coronavirus disease 2019-related condition for 5 of 21 women (23.8%): 3 (14.3%) before 32 weeks' gestation and 2 (9.5%) before 28 weeks' gestation. Oxygen support was required for 13 of 54 women (24.1%), including high-flow oxygen (n=2), noninvasive (n=1) and invasive (n=3) mechanical ventilation, and extracorporeal membrane oxygenation (n=1). Of these, 3, aged 35 years or older with positive test result for severe acute respiratory syndrome coronavirus 2 using reverse transcription polymerase chain reaction, had respiratory failure requiring indicated delivery before 29 weeks' gestation. All 3 women were overweight or obese, and 2 had an additional comorbidity. Coronavirus disease 2019 in pregnancy was associated with maternal morbidity and preterm birth. Its association with other well-known risk factors for severe maternal morbidity in pregnant women with no infection, including maternal age above 35 years, overweight, and obesity, suggests further studies are required to determine whether these risk factors are also associated with poorer maternal outcome in these women.

Sections du résumé

BACKGROUND
Despite the mainly reassuring outcomes for pregnant women with coronavirus disease 2019 reported by previous case series with small sample sizes, some recent reports of severe maternal morbidity requiring intubation and of maternal deaths show the need for additional data about the impact of coronavirus disease 2019 on pregnancy outcomes.
OBJECTIVE
This study aimed to report the maternal characteristics and clinical outcomes of pregnant women with coronavirus disease 2019.
STUDY DESIGN
This retrospective, single-center study includes all consecutive pregnant women with confirmed (laboratory-confirmed) or suspected (according to the Chinese management guideline [version 7.0]) coronavirus disease 2019, regardless of gestational age at diagnosis, admitted to the Strasbourg University Hospital (France) from March 1, 2020, to April 3, 2020. Maternal characteristics, laboratory and imaging findings, and maternal and neonatal outcomes were extracted from medical records.
RESULTS
The study includes 54 pregnant women with confirmed (n=38) and suspected (n=16) coronavirus disease 2019. Of these, 32 had an ongoing pregnancy, 1 had a miscarriage, and 21 had live births: 12 vaginal and 9 cesarean deliveries. Among the women who gave birth, preterm deliveries were medically indicated for their coronavirus disease 2019-related condition for 5 of 21 women (23.8%): 3 (14.3%) before 32 weeks' gestation and 2 (9.5%) before 28 weeks' gestation. Oxygen support was required for 13 of 54 women (24.1%), including high-flow oxygen (n=2), noninvasive (n=1) and invasive (n=3) mechanical ventilation, and extracorporeal membrane oxygenation (n=1). Of these, 3, aged 35 years or older with positive test result for severe acute respiratory syndrome coronavirus 2 using reverse transcription polymerase chain reaction, had respiratory failure requiring indicated delivery before 29 weeks' gestation. All 3 women were overweight or obese, and 2 had an additional comorbidity.
CONCLUSION
Coronavirus disease 2019 in pregnancy was associated with maternal morbidity and preterm birth. Its association with other well-known risk factors for severe maternal morbidity in pregnant women with no infection, including maternal age above 35 years, overweight, and obesity, suggests further studies are required to determine whether these risk factors are also associated with poorer maternal outcome in these women.

Identifiants

pubmed: 32553908
pii: S0002-9378(20)30639-6
doi: 10.1016/j.ajog.2020.06.022
pmc: PMC7294260
pii:
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

914.e1-914.e15

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Références

Am J Obstet Gynecol. 2020 Jun;222(6):521-531
pubmed: 32217113
Clin Infect Dis. 2020 Nov 19;71(16):2035-2041
pubmed: 32249918
J Infect. 2020 Mar 4;:
pubmed: 32145216
Am J Obstet Gynecol. 2020 Jul;223(1):111.e1-111.e14
pubmed: 32335053
AJR Am J Roentgenol. 2020 Jul;215(1):127-132
pubmed: 32186894
Lancet. 2020 Mar 7;395(10226):809-815
pubmed: 32151335
Ultrasound Obstet Gynecol. 2020 May;55(5):700-708
pubmed: 32160345
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Am J Obstet Gynecol. 2020 May;222(5):415-426
pubmed: 32105680
Expert Rev Hematol. 2016 Nov;9(11):1043-1061
pubmed: 27701915
N Engl J Med. 2020 Apr 23;382(17):e38
pubmed: 32268022
Clin Radiol. 2020 May;75(5):341-347
pubmed: 32216961
J Med Virol. 2020 Sep;92(9):1556-1561
pubmed: 32222119
Lancet Infect Dis. 2020 May;20(5):559-564
pubmed: 32220284
Am J Obstet Gynecol. 2020 Aug;223(2):286-290
pubmed: 32371056
Am J Obstet Gynecol MFM. 2020 May;2(2):100118
pubmed: 32292903
Obstet Gynecol. 2020 May;135(5):999-1002
pubmed: 32213786
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Clin Infect Dis. 2020 Jul 28;71(15):844-846
pubmed: 32119083
N Engl J Med. 2020 Apr 16;382(16):e34
pubmed: 32237670
Am J Obstet Gynecol. 2020 Jul;223(1):36-41
pubmed: 32311350
Am J Obstet Gynecol MFM. 2020 Feb;2(1):
pubmed: 32864602
Am J Obstet Gynecol. 2020 Aug;223(2):298-299
pubmed: 32348744
Am J Obstet Gynecol. 2020 Jul;223(1):109.e1-109.e16
pubmed: 32360108
Am J Obstet Gynecol MFM. 2020 May;2(2):100111
pubmed: 32518902
N Engl J Med. 2020 Aug 13;383(7):697
pubmed: 32790270
Transl Pediatr. 2020 Feb;9(1):51-60
pubmed: 32154135
Radiology. 2020 Aug;296(2):E32-E40
pubmed: 32101510
Acta Obstet Gynecol Scand. 2020 Jul;99(7):823-829
pubmed: 32259279
Lancet. 2020 Feb 22;395(10224):e40
pubmed: 32035511

Auteurs

Loïc Sentilhes (L)

Department of Obstetrics and Gynecology, Bordeaux University Hospital, Bordeaux, France. Electronic address: loicsentilhes@hotmail.com.

Fanny De Marcillac (F)

Department of Obstetrics and Gynecology, Strasbourg University Hospitals, Strasbourg, France.

Charlotte Jouffrieau (C)

Department of Obstetrics and Gynecology, Strasbourg University Hospitals, Strasbourg, France.

Pierre Kuhn (P)

Department of Neonatology, Strasbourg University Hospital, Strasbourg, France.

Vincent Thuet (V)

Department of Anesthesiology, Strasbourg University Hospitals, Strasbourg, France.

Yves Hansmann (Y)

Department of Infectious and Tropical Diseases, Strasbourg University Hospitals, Strasbourg, France.

Yvon Ruch (Y)

Department of Infectious and Tropical Diseases, Strasbourg University Hospitals, Strasbourg, France.

Samira Fafi-Kremer (S)

Virology Laboratory, Strasbourg University Hospitals, Strasbourg, France.

Philippe Deruelle (P)

Department of Obstetrics and Gynecology, Strasbourg University Hospitals, Strasbourg, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH